Researchers Identify Brain Regions Involved in Conversation
A recent NIDCD study mapped the brain during speech planning. The findings may lead to a better understanding of speech disorders such as stuttering.
Advances in Personalized Immunotherapy Hold Promise for Multiple Cancers
NIH researchers have found unique expression profiles in 50 genes that help identify rare anti-tumor lymphocytes that can infiltrate and help defeat metastatic solid epithelial tumors.
Researchers Document Third Case of HIV Remission Involving Stem Cell Transplant
A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART). The woman is the third known case of HIV remission following a stem cell transplant.
Silencing a Faulty Gene May Uncover Clues to Rare Forms of ALS
Using an experimental drug, researchers suppressed a mutated amyotrophic lateral sclerosis (ALS) gene. Studies in mice demonstrate the therapy shows potential in treating rare, aggressive forms of ALS caused by mutations in the fused in sarcoma (FUS) gene.
Signs of Mental Health Resilience in Youth During Pandemic
Survey data found that supportive relationships with family and friends and healthy behaviors—such as engaging in physical activity and better sleep—appeared to shield against the harmful effects of the pandemic on adolescents’ mental health.
Oral Immunotherapy Induces Remission of Peanut Allergy
An NIH clinical trial found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.
SARS-CoV-2 May Cause Fetal Inflammation
A small NICHD-led study showed that a SARS-CoV-2 infection during pregnancy may cause inflammatory immune responses in the fetus, even if the virus does not infect the placenta.
Survival Rate Increases for Extremely Preterm Infants
The survival rate of extremely preterm infants born from 2013 through 2018 in a large network of U.S. research centers improved to 78.3 percent.
Offering Buprenorphine to Inmates Has Hopeful Results
A study conducted in two rural Massachusetts jails found that people with opioid use disorder (OUD) who were incarcerated and received buprenorphine, a medication approved to treat OUD, were less likely to face re-arrest and reconviction after release.